PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmjcrInstructions for authorsCurrent ToCBMJ Case Reports
 
BMJ Case Rep. 2010; 2010: bcr11.2009.2446.
Published online Apr 5, 2010. doi:  10.1136/bcr.11.2009.2446
PMCID: PMC3047516
Rare disease
Positive psoas sign in presentation of retroperitoneal malignant triton tumour
Christopher Toby Winterbottom
King’s College Hospital London, Emergency Department, King’s College Hospital, Denmark Hill, London, SE5 9RS, UK
Correspondence to Christopher Toby Winterbottom, tobywinterbottom/at/doctors.org.uk
This article describes a case of a rare malignant neoplasm presenting to the emergency department with common symptomatology and its subsequent identification using a simple physical examination technique. Discussion includes a description of this rare soft tissue sarcoma and a consideration of the value of the psoas sign as a part of the routine abdominal exam to detect intra-abdominal and retroperitoneal pathology. In conclusion, this article acts as a reminder to all clinicians that uncommon and significant pathology may present to the emergency department masquerading as a common, seemingly benign, complaint, but can be clinically identified using simple techniques available to all and rapidly investigated using appropriate special investigations.
This case is important because it was a presentation of an exceedingly rare malignancy (of a type that the doctors involved in the case had never encountered before). Regardless of the resultant diagnosis and treatment (requiring the multidisciplinary coordination), significant pathology was quickly identified in the emergency department after multiple presentations to different healthcare professionals over the course of a prolonged period. Why this case is important is that it highlights the use of thorough physical examination, extensions to the routine physical examination and the prerequisite for an open mind and a high index of clinical suspicion of unusual presentations in the emergency department.
A 31 year-old woman with no significant past medical or family history presented to the emergency department complaining of left hip pain. Symptoms had been present for over 1 year, with an increase in severity and frequency of episodes over the preceding 3 months; developing pain at night that disrupted sleep, most pronounced while lying supine. At the time of assessment the pain had become constant with no relief from simple oral analgesia (combined oral paracetamol, ibuprofen and codeine), gnawing in nature, with occasional radiation to the ipsilateral groin and loin. There was no history of injury, systemic symptoms of infection, lumbosacral pathology, gastrointestinal or genitourinary symptoms, and no recent pregnancy (her most recent child was 2-years-old at the time of presentation). She had been assessed by her family doctor on numerous occasions and referred for physiotherapy; routine plain hip and pelvis radiographs had revealed no bone or joint abnormality, and she was due to attend orthopaedics outpatients for further assessment the following week. Intractable pain motivated presentation.
Her examination revealed she was apyrexial, normotensive, with normal pulse and respiratory rates. Cardiovascular and respiratory examination was unremarkable. Abdominal examination revealed a Pfannenstiel scar from lower segment Caesarean section 2 years previously. Deep palpation of her abdomen during routine examination revealed some mild tenderness in the left iliac fossa with no masses palpable. Hip examination revealed no bony or joint line tenderness. On assessing hip range of movement, passive extension of the hip caused a marked exacerbation of pain with radiation to the left loin. Further formal testing of psoas irritation (hip flexion against resistance) replicated pain. Neurological examination of the lower limbs (motor, sensory and reflex function) was entirely normal with no discrepancy between the lower limbs. The patient displayed no autonomic dysfunction in the lower limbs (comparable temperature and perfusion). Examination of sacral innervation revealed no saddle anaesthesia and normal anal tone, with no tenderness on digital rectal examination. Bimanual pelvic examination revealed no cervical excitation or adnexal tenderness.
Routine blood tests revealed no evidence of raised white cells, inflammatory markers, renal impairment or pregnancy. Urine dipstick testing revealed no evidence of infection or haematuria. Liver function tests revealed mildly elevated alkaline phosphatase (ALP), alanine transaminase (ALT), aspartate aminotransferase (AST) and gGT. On discussion with the duty radiology consultant, CT abdomen (with contrast) was completed revealing a well-defined left-sided retroperitoneal soft tissue lesion measuring 6.1×4.4×7.7 cm abutting the left psoas, adjacent to, but not invading, the spleen, left kidney, diaphragm and 11th rib (see figure 1).
Figure 1
Figure 1
Images from CT scan of the abdomen (venous phase) revealing retroperitoneal mass (arrowed). (a) Axial section at the level of the lower border of T12 vertebral body; (b) Saggital view of the left retroperitoneal space revealing an encapsulated mass; (c) (more ...)
Differential diagnosis
Differential diagnosis (based on the CT result) was of retroperitoneal sarcoma, lymphoma or neural lesion. These were the potential differential diagnoses based on the scan interpretation by the on-call consultant radiologist. On further enquiry, the relatively broad differential diagnosis of a ‘neural lesion’ was based on the proximity of the soft tissue mass to the spinal column and spinal nerve roots on the left side.
Included in the rationale for CT imaging was psoas abscess, retroperitoneal fibrosis, retroperitoneal mass/malignancy and local (psoas) nerve root irritation.
Treatment
The patient was subsequently referred to the regional neurosurgical centre with the advice of oncologists to surgically remove the tumour en masse rather than biopsy in the first instance. This was achieved after further MRI imaging (identifying a left retroperitoneal mass in the quadratus lumborum, with extension to the T12 neural foramen, suggesting neurofibroma or Schwannoma).
Operative findings were macroscopically consistent with neurofibroma, with tumour removal achieved to the cut margin of T12 nerve root. Her post-operative recovery was uneventful, with resolution of pain and no further neurological symptoms.
Examination of histological specimens revealed a malignant nerve sheath tumour, displaying elements of rhabdomyosarcomatous change, consistent with a diagnosis of malignant triton tumour, with extension to the excision edges. CT and MRI scans of chest, abdomen and pelvis revealed no evidence of organ or lymph node metastasis (despite initial derangement of serum liver enzymes). Multidisciplinary team meetings, again with the assistance of the oncology specialists, proposed adjuvant radiotherapy. This was after discussion regarding the risks and benefits of further surgery (the risk of cerebrospinal malignant seeding was thought to negate potential benefit). The patient received 50 + 4 Gy regional and targeted radiotherapy, with inevitable irradiation of the left kidney.
At present the patient is recovering well with no further symptoms and is due for further surveillance with repeat MRI (to monitor local recurrence) and renal function tests after 2 months.
Malignant nerve sheath peripheral tumours (MNSPTs), a type of soft tissue sarcoma, arise from Schwann cells of peripheral neural tissue or within existing neurofibromas (in patients with existing neurofibromatosis). A malignant triton tumour (MTT) is a histological subdivision of these tumours, with diagnosis based on the finding of rhabdomyosarcomatous differentiation alongside malignant Schwannoma on biopsy. In 50–69% of patients, MTT is diagnosed in the presence pre-existing neurofibromatosis type 1 (NF-1 or Von Recklinghausen’s disease).1,2
The annual incidence of soft tissue sarcomas in the USA—from data of the 2006 report from Surveillance Epidemiology and End Results branch of National Cancer Institute—is estimated as 12.8 per million per year in the 25–29-year-old age group for the year 2000 (11.3 per million in period 1975–2000).3 One estimate is that malignant peripheral nerve sheath tumours constitute 5–10% of tumours within this classification group,4 or 0.0001% in the general population,5 and that ‘on occasion’ they can be shown to be a MTT.6 Beyond this, the precise incidence of MTT remains unknown. It is considered to be relatively rare and as a result has been described predominantly in single case reports and small case series.7
Classification criteria for MTT were proposed by Woodruff et al in 1973 following early case reports of MTT. To determine whether or not a tumour is truly a MTT, three criteria have been proposed: (1) the tumour arises along a peripheral nerve, in a ganglioneuroma, or in a patient with NF-1 or represents a metastasis from such a tumour; (2) the tumour has the growth characteristics of a Schwann cell tumour; and (3) rhabdomyoblasts can be demonstrated arising within the body of the tumour.8 On diagnosis, the grade of tumour can be further divided as described in table 1.
Table 1
Table 1
American Joint Committee on Cancer Staging System for Soft Tissue Sarcomas (6th edition)9
The treatment of MTT is primarily surgical, although in certain cases (dependent on the above grading system) adjuvant chemotherapy or radiotherapy may be appropriate to prevent recurrence or propagation in situations of incomplete resection. Adjuvant chemotherapy has been described as ‘ineffective’,10 although one case was reported in which recurrent MTT was found to express retinoic acid receptors α and γ and the patient treated successfully (to 3 years with no evidence of recurrence) with targeted isotretinoin and interferon-α.11
Radiotherapy is also considered to be less useful for retroperitoneal soft tissue sarcomas compared to limb extremity cases and local recurrence rates for retroperitoneal tumours range from 40–80% overall. Local recurrence in the absence of metastasis can be and is often the primary cause of mortality in these patients. The prognosis for MPNSTs (as a disease group) is poor, with death occurring in 63% within 2 years of diagnosis.12 MTTs behave more aggressively than classic MPNSTs, with crude 2-year and 5-year survival rates of 15% and 11%, respectively.13
Psoas sign (psoas stretch test)
Eliciting the psoas sign exploits the irritation of psoas in its course through the retroperitoneal space.
Anatomy
Psoas is a retroperitoneal muscle that originates from the lateral borders of the twelfth thoracic to fifth lumbar vertebrae. Psoas has two fibrous and one fascial attachment on the spine. Fascicles attach posteriorly to the L1–L5 transverse processes and anteriorly from the T12–L1 disc to the L4–L5 disc. In 70% of people, it is a single structure (psoas major), but 30% also have a smaller psoas minor muscle, which lies anterior to the psoas major along the same course. It is innervated by ventral rami of the lumbar spinal nerves T12–L4.14 Psoas has attachments to the diaphragm and pelvic floor. At the inferior aspect of the muscle (within the pelvis) it combines with the iliacus muscle (arising from the anterior and medial surface of the ilium) to form the iliopsoas. The iliopsoas then traverses the pelvis, exits anteriorly over the superior pubic ramus and inserts into the lesser trochanter of the femur.15
The primary function of psoas is as a hip flexor—that is, when the body is fixed bringing the upper leg towards the body or when the leg is fixed bringing the body towards the leg (sitting from a supine position). Psoas is also selectively involved in sitting with a straight back and in contralateral loading situations requiring stabilisation of the spine in the frontal plane—that is, as a muscle maintaining truncal posture.16 Psoas also performs minimal external rotation and adduction when the femur is moving from an abducted position at the hip and minimal adduction when the hip is fully flexed.17
Eliciting psoas sign
In order to elicit the psoas sign, it is necessary to both resist activity of psoas and induce stretch by passively extending the muscle. To test active movement have the patient lying supine and, with the pelvis remaining in neutral alignment and the contralateral leg extended on the bed, ask the patient to bend the knee towards the chest, flexing at the hip. Once the lower leg is parallel to the bed the examiner places one hand on the patient’s distal thigh (resisting hip flexion), while stabilising the lower leg with the other hand (figure 2a). If psoas irritation is present, the additional load from resisting flexion will induce or reproduce pain. To complete examination of psoas ask the patient to roll over and lie in the lateral decubitus position the legs extended (the side being examined should be uppermost; thus, to examine psoas on the right the patient should be in the left lateral decubitus position and vice versa. Next the examiner, keeping the pelvis stabilised with one hand, extends the leg at the hip (while maintaining extension at the knee; figure 2b). Again, passive extension stretches psoas and its overlying fascium (anterior thoracolumbar fascium) causing irritation and pain.
Figure 2
Figure 2
Eliciting the psoas sign. (a) With the patient supine resist active hip flexion. (b) In the lateral decubitus position passively extend outstretched leg at the hip. In both instances the presence of or increase in pain on these manoeuvres represents a (more ...)
Significance of a positive psoas sign
In the assessment of the patient in this report the identification of psoas irritation prompted the appropriate use of CT as the initial imaging modality to investigate retroperitoneal pathology,18 and ultimately led to the diagnosis and definitive treatment of malignant neoplasm over 1 year after the onset of symptoms, after assessment by a number of medical professionals. To this end, it was an invaluable part of the physical examination. A review of the literature reveals a well described phenomenon, ‘malignant psoas syndrome’, first described by Stevens et al (1990)19 in which psoas irritation can represent the initial manifestation of a primary malignant process within psoas or as a result of metastatic spread to psoas due to a range of primary malignancies. It can be characterised by proximal lumbosacral plexopathy, painful fixed flexion of the ipsilateral hip and radiological or pathological evidence of ipsilateral psoas muscle malignant involvement.20
How useful is the psoas stretch test in other clinical contexts? Use of the psoas sign is only commonly suggested as an addition to abdominal examination in two clinical situations: suspected psoas abscess and acute appendicitis.21
In the context of appendicitis, pain results because the psoas borders the peritoneal cavity posteriorly so stretching (by hyperextension at the hip) or contraction (by flexion of the hip) of the muscles causes friction against inflamed peritoneum. The right iliopsoas muscle lies under the appendix when the patient is supine; thus, a positive psoas sign on the right may suggest acute appendicitis. Wagner et al (1996) completed a comprehensive systematic review in which various physical symptoms and signs were assessed and then correlated to diagnostic specificity and sensitivity after post-operative confirmation of appendicitis. The data from three separate trials (assessing a number of pre-operative diagnostic examination techniques to aid identification of appendicitis) were analysed retrospectively. In the context of the diagnostic effectiveness of the psoas sign in evaluating acute appendicitis the authors identified 450 cases in which psoas sign had been recorded prior to surgery and made an assessment of its suitability as a useful clinical sign. In this combined series, the sensitivity is quoted as 16% and specificity as 95%. This in combination with calculated positive and negative likelihood ratios led the authors to conclude that psoas sign is helpful if present in the context of acute appendicitis (but not helpful if absent).22
No such comprehensive data exist regarding the use of psoas sign in suspected psoas abscess, although case reports would suggest that psoas sign is only positive in up to 66% of cases.23 Thus, absence of psoas sign is not discriminatory in the assessment of psoas abscess. Despite this, Taiwo (2001) argues that the psoas test should form an integral part of the examination, particularly in cases where symptoms could be attributed to other more common causes of abdominal, pelvic or hip pain.24
Learning points
  • While ‘common things are common’, rare conditions can frequently present to the emergency department.
  • The addition of the psoas stretch test can add additional information to the physical examination allowing a degree of assessment of the retroperitoneal space.
  • Classically psoas stretch test is of use in the assessment acute appendicitis and psoas abscess, although the sensitivity in these conditions is low.
  • CT is the appropriate initial choice of imaging modality to visualise the retroperitoneum.
Footnotes
Competing interests: None.
Patient consent: Patient/guardian consent was obtained for publication.
1. Stasik CJ, Tawfik O. Malignant peripheral nerve sheath tumor with rhabdomyosarcomatous differentiation (malignant triton tumor). Arch Pathol Lab Med 2006; 130: 1878–81. [PubMed]
2. Malerba M, Garofalo A. A rare case of nerve-sheath sarcoma with rhabdomyoblastic differentiation (malignant triton tumor). Tumori 2003; 89: 246–50. [PubMed]
3. Bleyer A, O’Leary M, Barr R, Ries LAG, editors. , eds. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975–2000. National Cancer Institute, 2006.
4. Weiss SW, Goldblum JR. Malignant tumors of the peripheral nerves. : Strauss M, editor. , ed. Soft Tissue Tumors. 4th edn Mosby, 2001: 1209–30.
5. Malerba M, Garofalo A. A rare case of nerve-sheath sarcoma with rhabdomyoblastic differentiation (malignant triton tumor). Tumori 2003; 89: 246–50. [PubMed]
6. Geller DS, Gebhardt M. Malignant Nerve Sheath Tumors. Electronic Sarcoma Update Newsletter June 2006; 3.
7. Naganuma H, Funaoka M, Fujimori S, et al. Malignant triton tumor in a patient with neurofibromatosis type 1. J Med Ultrasound June 2007; 34: 107–111.
8. Woodruff JM, Chernik NL, Smith MC, et al. Peripheral nerve tumors with rhabdomyosarcomatous differentiation (malignant “triton” tumors). Cancer 1973; 32: 426–39. [PubMed]
9. Greene FL, Page DL, Fleming ID, editors. , eds. American Joint Committee on Cancer Cancer Staging Manual. 6th ed. New York: Springer, 2002.
10. Malerba M, Garofalo A. A rare case of nerve-sheath sarcoma with rhabdomyoblastic differentiation (malignant triton tumor). Tumori 2003; 89: 246–50. [PubMed]
11. Kostler WJ, Amann G, Grunt TW. Recurrent malignant triton tumor: first report on a long-term survivor. Oncol Rep 2003; 10: 533–5. [PubMed]
12. Woodruff JM, Perino G. Non-germ-cell or teratomatous malignant tumors showing additional rhabdomyoblastic differentiation, with emphasis on the malignant triton tumor. Semin Diagn Pathol 1994; 11: 69–81. [PubMed]
13. Hruban RH, Shiu MH, Senie RT, et al. Malignant peripheral nerve sheath tumors of the buttock and lower extremity: a study of 43 cases. Cancer 1990; 66: 1253–26. [PubMed]
14. Sean GT, Gibbons PT. A review of the anatomy, physiology and function of psoas major - a new model of stability. Proceedings of the 11th Annual National Orthopedic Symposium, November 1999, Halifax, Canada.
15. Busick N, Brandser E, Sandra A. Pelvis and Perineum Muscular Anatomy. Electric Differential Multimedia Laboratory, Department of Radiology, University of Iowa College of Medicine, November 2006.
16. Andersson E, Oddson L. The role of the psoas and iliacus muscles for stability and movement of the lumbar spine, pelvis and hip. Scand J Med Sci Sports 2007; 5: 10–16. [PubMed]
17. Skyrme AD, Cahill DJ, Marsh HP, et al. Psoas major and its controversial rotational action. Clin Anat 1999; 12: 264–5. [PubMed]
18. Isaac B, Kernbaum S, Burke M. Unexplained fever: a guide to the diagnosis and management of febrile states in medicine, surgery, pediatrics, and subspecialties. CRC Press, 1991: 499–501.
19. Stevens MJ, Gonet YM. Malignant psoas syndrome: recognition of an oncologic entity. Australas Radiol 1990; 34: 150–4. [PubMed]
20. Agar M, Broadbent A, Chye R. The management of malignant psoas syndrome: case reports and literature review. J Pain Symptom Manage 2004; 28: 282–93. [PubMed]
21. Bickley LS, Szilagyi PG. Bates’ Guide to Physical Examination and History Taking, Ninth Edn Lippincott Williams & Wilkins, June 2007: 390.
22. Wagner JM, McKinney P, Carpenter JL. Does this patient have appendicitis? J Am Med Assoc 1996; 276: 1589–94. [PubMed]
23. Melissas J, Romanos J, de Bree E, et al. Primary psoas abscess. Report of three cases. Acta Chir Belg 2002; 102: 114–7. [PubMed]
24. Taiwo B. Psoas Abscess: A primer for the internist. South Med J 2001; 94: 2–5. [PubMed]
Articles from BMJ Case Reports are provided here courtesy of
BMJ Group